Sign in to continue:

Friday, February 20th, 2026

Three-A Resources Eyes Recovery Amid Technical Buy Signals

Date: October 21, 2024
Broker: CGS International Securities Malaysia Sdn. Bhd.

Company Overview

Three-A Resources is a company involved in the food and beverage sector, producing a range of products, including food additives and ingredients. The company plays a significant role in supplying essential components used in food processing and manufacturing.

Recent Stock Performance

  • Last Price: RM 0.885
  • The stock has been experiencing a slight downward trend, currently trading below the initial entry price. Despite the minor drop, the company remains part of the actively managed portfolio as it continues to show potential for a recovery.

Technical Analysis

  • Entry Price: RM 0.930
  • Current Price: RM 0.885
  • Stop Loss: RM 0.850
  • Target Prices: RM 0.975, RM 1.00, RM 1.13

Trading Position

  • Current Position: Buy
  • Weighting in Portfolio: 8%
  • Shares Held: 107,500
  • Total Cost: RM 99,975.00
  • Market Value: RM 95,137.50
  • Profit/Loss: -RM 4,837.50 (-4.8%)

Trading Recommendation

The stock is currently held in a “Buy” position within the actively managed portfolio. While there is a short-term loss, the technical analysis suggests the possibility of a recovery with potential upside targets of RM 0.975, RM 1.00, and RM 1.13. The stop loss is set at RM 0.850 to manage potential downside risks.

Conclusion

Three-A Resources remains a part of the portfolio despite recent underperformance. The company is seen as having recovery potential, with clear target prices set for future gains. Traders are advised to monitor the position closely, adhering to the stop-loss level for risk management.

GSH Corp Stock Surges: Technical Buy Signal Emerges with Bullish Reversal and Increased Momentum

Comprehensive Company Analysis: CGS Trendspotter Report (January 20, 2025) Comprehensive Company Analysis: CGS Trendspotter Report (January 20, 2025) Broker: CGS Trendspotter Date of Report: January 20, 2025 Introduction The latest CGS Trendspotter report unveils...

VISEN Pharmaceuticals’ HK$672 Million IPO: Pioneering Endocrine Therapies in Hong Kong’s Biotech Boom

​Visen Pharmaceuticals, a biopharmaceutical company specializing in endocrinology treatments in China, is set to list on the Hong Kong Stock Exchange under the ticker 02561.HK. The IPO is scheduled for March 21, 2025, aiming...

Market Pulse: Global Stocks Retreat as Rally Fades, HSBC and JD.com Show Resilience

Comprehensive Market Analysis: ComfortDelGro, Boustead Singapore, JD.com, and HSBC Comprehensive Market Analysis: ComfortDelGro, Boustead Singapore, JD.com, and HSBC By OCBC Investment Research | 18 Nov 2024 ComfortDelGro Corporation: Acquisition-Fueled Growth ComfortDelGro Corporation (CD SP)...

   Ad